NCT01538420View on ClinicalTrials.gov

GLPG0492 Pharmacodynamics

PHASE1CompletedINTERVENTIONAL

Enrollment

26

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

March 31, 2012

Study Completion Date

April 30, 2012

Conditions

Healthy

Interventions

DRUG

GLPG0492

Oral solution

DRUG

Placebo

Placebo oral solution

Trial Locations (1)

Unknown

SGS Stuivenberg, Antwerp

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Galapagos NV

INDUSTRY

NCT01538420 - GLPG0492 Pharmacodynamics | Biotech Hunter | Biotech Hunter